Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus
On the political front, Robert F. Kennedy Jr. will become the next HHS secretary after he attained a majority of Senate votes ...
Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more
From consumer to healthcare, here's a list of key deals reported this week: Papa John's (NASDAQ:PZZA) jumped 18% on a report that a Qatari-backed investor is considering a takeover of the pizza chain.
Blackstone, Corsair Capital looking to sell off First Eagle: report
Blackstone (NYSE:BX) and Corsair Capital are looking to sell First Eagle Investment Management for more than $4B, the Financial Times reported late Friday, citing people briefed on the matter.
pharmaphorum21h
Novartis gets FDA OK for first in its trio of IgAN therapies
Novartis has claimed accelerated approval ... while zigakibart is in phase 3. In 2021, Calliditas Therapeutics' corticosteroid-based Tarpeyo (budesonide) became the first FDA-approved therapy ...
pharmaphorum21h
Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn
Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.
Novartis17h
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.